InterVenn is a life science company unlocking the value of glycoproteomics—glycosylated proteins which are responsible for driving protein function—for the development of transformational healthcare solutions. The glycoproteome is a source of life-critical information about human biology that has the potential to improve patient outcomessignificantly. Still, it has remained inaccessible due to its vast complexity. InterVenn has pioneered a first-of-its-kind AI-powered platform to decode this layer of biology at a clinically meaningful scale for the first time in history. The company’s platform can produce a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and, potentially, therapeutics. Its proprietary technology platform is accessible to pharma partners seeking rich biology insights to propel their research and development efforts. Founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert & serial entrepreneur Aldo Carrascoso, InterVenn will contribute to making the new era of personalized, predictive, and preventative care a reality. For more information about InterVenn, visit www.intervenn.com.

AI/ML

Biotechnology

Health Care

InterVenn Biosciences

Frederico Alisson da Silva

Kiat Yee Liow, Ph.D.

Maurice Wong

Meghan Grech

Rachel Rice

Regina Ramos

Ankita Shah

Hardiyanti Nirwan Ben

Noramira Saad

Norton Kitagawa

Charmie Raterta , CPA

Daniel Serie

James Richard Hartness Jr

Kaitlynn Moser

Rudy Peters

Jessie Siat

Maichel Empredo

Anjo Zulaybar

Ruth Tria, CPA

Tal K.

Harold Viduya

Jojo Santos

Katelyne Arda

Kristal Kamatoy

Alex Vanotti

The Engineering and Development team at InterVenn Biosciences is responsible for designing and implementing the innovative software infrastructure needed to support the company's AI-powered platform for glycoproteomics analysis. This team collaborates on developing robust, scalable applications that enable the decoding of complex biological data, ensuring reliability through rigorous quality assurance practices. By leveraging their expertise in software engineering, the team contributes to advancing the capabilities of clinical applications that enhance patient outcomes in the field of personalized medicine.

Engineering and Development

Clinical Research and Data Analysis

Business Operations and Support

��

Engineering and Development

About

Team members

Other teams at InterVenn Biosciences

Clinical Research and Data Analysis

Business Operations and Support

��������

Engineering and Development

About

Team members

Other teams at InterVenn Biosciences

Clinical Research and Data Analysis

Business Operations and Support

��